Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations
By A. Bhowmik, T. Seemungal, R. J. Sapsford, J. Wedzicha. Thorax, 2000
805 citations recorded by the source corpus.
Subfields: Emergency Medical Services, Pulmonary and Respiratory Medicine, Sociology and Political Science
View Paper: https://www.semanticscholar.org/paper/6a9899bbdc3255c94b84f59208c8e087986b6d88
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Emergency Medical Services
In Pulmonary and Respiratory Medicine
In Sociology and Political Science
Citations in the corpus
- Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. (2012, neutral): “Secondary analysis of health status, symptom scores, lung function, and treatment failures was performed in (1) blood eosinophil biomarker-positive and biomarker-negative exacerbations, (2) blood eosinophil biomarker-negative exacerbations prescribed prednisolone and placebo, and (3) blood eosinophi”
- Mediators of Chronic Obstructive Pulmonary Disease (2004, background): “C. Interleukin-6 IL-6 concentrations are increased in induced sputum, bronchoalveolar lavage, and exhaled breath condensate of COPD patients, particularly during exacerbations (Bhowmik et al., 2000; Song et al., 2001; Bucchioni et al., 2003).”